Group A | Group B | |
---|---|---|
Number of patients | 105 | 33 |
Number of eyes | 115 | 33 |
Baseline | ||
VA (mean ± SD) | 57.9 ± 14.9 | 62.4 ± 12.4 |
p-value | 0.0850 | |
4 months | ||
VA (mean ± SD) | 63.6 ± 14.5 | 66.8 ± 12.4 |
Change in mean VA (95% CI) | 5.5 | 5.4 |
95% CI | [3.7; 7.2] | [2.0; 8.7] |
p-value | < 0.0001 | 0.0017 |
Difference in mean VA changes | 0.1 | |
95% CI | [−3.7; 3.9] | |
p-value | 0.9619 | |
12 months | ||
VA (mean ± SD) | 64.6 ± 15.8 | 68.5 ± 14.4 |
Change in mean VA (95% CI) | 6.5 | 6.9 |
95% CI | [4.4; 8.6] | [3.0; 10.9] |
p-value | < 0.0001 | 0.0008 |
Difference in mean VA changes | −0.5 | |
95% CI | [−5.0; 4.0] | |
p-value | 0.8378 | |
18 months | ||
VA (mean ± SD) | 64.0 ± 15.0 | 65.8 ± 15.5 |
Change in mean VA (95% CI) | 6.0 | 4.3 |
95% CI | [3.7; 8.3] | [0.1; 8.6] |
p-value | < 0.0001 | 0.0467 |
Difference in mean VA changes | 1.7 | |
95% CI | [−3.1; 6.5] | |
p-value | 0.4952 | |
24 months | ||
VA (mean ± SD) | 64.8 ± 15.6 | 63.2 ± 17.3 |
Change in mean VA (95% CI) | 7.0 | 1.2 |
95% CI | [4.7; 9.3] | [−3.1; 5.6] |
p-value | < 0.0001 | 0.5733 |
Difference in mean VA changes | 5.7 | |
95% CI | [0.8; 10.6] | |
p-value | 0.0224 |